IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Richard Belanger who wrote (304)	1/22/1997 6:54:00 PM
From: Brad C. Dunlap	of 1762

Hi Richard, I have my Coulter info at the office so tomorrow I'll report the dosage of I-131. You bring up a real important issue and in the Coulter prospectus they highlight that there is a chance that Coulter's product will be administered in an outpatient setting depending on the new requirements. However, they do say that even if the federal government does relax the radiation requirements there is a strong chance that the individual states will have the last say on this matter. Please keep us posted on any additional info that you hear.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next